205 related articles for article (PubMed ID: 11248024)
1. From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells.
Kang HY; Lin HK; Hu YC; Yeh S; Huang KE; Chang C
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3018-23. PubMed ID: 11248024
[TBL] [Abstract][Full Text] [Related]
2. SMAD3 represses androgen receptor-mediated transcription.
Hayes SA; Zarnegar M; Sharma M; Yang F; Peehl DM; ten Dijke P; Sun Z
Cancer Res; 2001 Mar; 61(5):2112-8. PubMed ID: 11280774
[TBL] [Abstract][Full Text] [Related]
3. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.
Chipuk JE; Cornelius SC; Pultz NJ; Jorgensen JS; Bonham MJ; Kim SJ; Danielpour D
J Biol Chem; 2002 Jan; 277(2):1240-8. PubMed ID: 11707452
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4.
Kang HY; Huang KE; Chang SY; Ma WL; Lin WJ; Chang C
J Biol Chem; 2002 Nov; 277(46):43749-56. PubMed ID: 12226080
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
7. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
8. DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells.
Song K; Wang H; Krebs TL; Wang B; Kelley TJ; Danielpour D
Mol Endocrinol; 2010 Oct; 24(10):2019-29. PubMed ID: 20739403
[TBL] [Abstract][Full Text] [Related]
9. Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells.
Masiello D; Chen SY; Xu Y; Verhoeven MC; Choi E; Hollenberg AN; Balk SP
Mol Endocrinol; 2004 Oct; 18(10):2388-401. PubMed ID: 15256534
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
11. Stromal TGF-β signaling induces AR activation in prostate cancer.
Yang F; Chen Y; Shen T; Guo D; Dakhova O; Ittmann MM; Creighton CJ; Zhang Y; Dang TD; Rowley DR
Oncotarget; 2014 Nov; 5(21):10854-69. PubMed ID: 25333263
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation.
Cheng PL; Chang MH; Chao CH; Lee YH
Oncogene; 2004 Oct; 23(47):7821-38. PubMed ID: 15334054
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
14. The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer.
Mukhopadhyay NK; Cinar B; Mukhopadhyay L; Lutchman M; Ferdinand AS; Kim J; Chung LW; Adam RM; Ray SK; Leiter AB; Richie JP; Liu BC; Freeman MR
Mol Endocrinol; 2007 Sep; 21(9):2056-70. PubMed ID: 17550981
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
van der Poel HG
Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
[TBL] [Abstract][Full Text] [Related]
16. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells.
Yeh S; Miyamoto H; Nishimura K; Kang H; Ludlow J; Hsiao P; Wang C; Su C; Chang C
Biochem Biophys Res Commun; 1998 Jul; 248(2):361-7. PubMed ID: 9675141
[TBL] [Abstract][Full Text] [Related]
17. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators.
Yanagisawa J; Yanagi Y; Masuhiro Y; Suzawa M; Watanabe M; Kashiwagi K; Toriyabe T; Kawabata M; Miyazono K; Kato S
Science; 1999 Feb; 283(5406):1317-21. PubMed ID: 10037600
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
19. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
Alexander B; Fishman AI; Green D; Choudhury MS; Konno S
Urol Oncol; 2013 Jan; 31(1):104-9. PubMed ID: 21795077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
